Naltrexone Underprescription — August 2024

August posts focused on one clear problem: naltrexone helps reduce alcohol cravings, but doctors don’t prescribe it enough. If you or someone you care about struggles with heavy drinking, this month’s content explains why naltrexone matters, what gets in the way of its use, and simple next steps.

Why naltrexone gets overlooked

Naltrexone has solid evidence for cutting cravings and lowering heavy drinking days, yet many patients never hear about it. Barriers include limited clinician familiarity, worries about liver safety, and stigma around medication for addiction. Some clinics favor counseling alone and may not offer medication-assisted options. Researchers in August highlighted that better education for prescribers and clearer clinic pathways could fix this gap.

Another practical barrier: follow-up and monitoring. Prescribers sometimes avoid starting a medicine they feel they can’t monitor properly. That’s fixable with simple routines — baseline liver tests, a short check-in after two weeks, then monthly reviews.

Practical steps — what to know and do

Here’s what patients and families should know. Naltrexone comes in two common forms: a daily tablet (usually 50 mg) and a monthly injection (380 mg). Side effects can include nausea, headache, and dizziness; most people tolerate it fine. It’s not safe for people who are taking opioids or who are in acute opioid withdrawal, because naltrexone blocks opioids and can cause severe withdrawal.

Combine medication with therapy. The August article stresses that naltrexone works best with counseling, mutual-support groups, or structured behavioral therapy. If a single approach hasn’t worked, adding medication may reduce cravings enough for therapy to stick.

For prescribers: consider offering naltrexone more often, especially when patients report strong cravings or repeated heavy drinking episodes. Discuss dosing openly, set a follow-up plan, and talk about the injectable option for people who struggle with daily pills. When researchers talk about combining medications, they mean tailoring treatment — sometimes adding acamprosate or optimizing psychosocial care improves outcomes.

For patients: ask your clinician about medication options. A plain question like, “Could naltrexone help reduce my cravings?” opens the door. If your provider isn’t familiar, suggest a referral to addiction medicine or ask about telehealth consultations. Bring up any liver disease or opioid use so the clinician can choose the safest option.

August’s coverage makes a clear point: naltrexone is underused, but it’s a practical tool. With basic monitoring and combined behavioral support, many people can reduce drinking and regain control. Ask the question, get the facts, and consider medication-assisted treatment as part of a real plan — not a last resort.